SLU PP 332 250mcg Tablets (60)

SLU‑PP‑332 – 250 mcg per tablet (Research‑Grade Molecule)
Estrogen‑Related Receptor Pan‑Agonist / Exercise‑Mimetic
For Research Use Only

Product Description:
SLU‑PP‑332 (also known as SR‑9861) is a synthetic small‑molecule pan‑agonist of estrogen‑related receptors (ERRα, ERRβ, ERRγ), with highest potency at ERRα (EC₅₀ ≈ 98 nM; ERRβ ≈ 230 nM; ERRγ ≈ 430 nM)  . It is extensively investigated as an exercise mimetic, enhancing mitochondrial function, energy expenditure, fatty acid oxidation, and skeletal muscle oxidative capacity in preclinical models  .

Research Applications:
SLU‑PP‑332 has been evaluated in laboratory and animal studies for its capacity to:

Enhance mitochondrial respiration and metabolic activation in muscle cells.
Mimic genetic responses associated with aerobic exercise, including upregulation of genes like DDIT4 and Pdk4.
Improve exercise endurance, promoting a shift toward oxidative muscle fibre types in rodents.
Support metabolic syndrome improvements: reduced adiposity, enhanced insulin sensitivity, and weight loss in obese mouse models, without altering food intake or activity levels.

Dosage Form:
Delivered in tablet or capsule form, each containing 250 μg of SLU‑PP‑332. Typically supplied as a 60-capsule bottle for controlled research dosing.

Storage & Handling:
Store in a cool, dry environment (20–25 °C), protected from light and moisture.
For laboratory research only; not for clinical or in vivo therapeutic use.

Chemical Information:
Component: SLU‑PP‑332
Synonyms: SLU‑PP‑332, SR‑9861, 4-Hydroxy‑N’‑(naphthalen-2‑ylmethylene)benzohydrazide
CAS Number: 303760‑60‑3
Molecular Formula: C₁₈H₁₄N₂O₂
Molecular Weight: ~290.32 g/mol
Purity: ≥98% (HPLC verified; typical ≥99% per vendor COAs)

Important Notice:
This product is provided exclusively for laboratory research use by qualified professionals. It is not intended for human or animal use, nor for therapeutic, diagnostic, or clinical applications.